Prostate cancer (PCa) epidemiology and management in the United States have been found to differ across regions. It is well known that there are higher PCa mortality rates among black men compared with white men, although these are statistically significant in only a handful of areas.1 In addition, conservative management for low-risk PCa in the Veterans Affairs (VA) healthcare system is used more frequently in facilities in the Midwest and West than among those in the Northeast.2 Also, radical prostatectomy (RP) for localized PCa is used to a greater extent in the Midwest and High Plains regions and used least in the South Atlantic region.3